ProQR Therapeutics
PRQR
PRQR
47 hedge funds and large institutions have $15.9M invested in ProQR Therapeutics in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 16 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
50% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 16
Holders
47
Holding in Top 10
–
Calls
$41K
Puts
$1K
Top Buyers
| 1 | +$483K | |
| 2 | +$279K | |
| 3 | +$138K | |
| 4 |
Two Sigma Advisers
New York
|
+$87.4K |
| 5 |
Morgan Stanley
New York
|
+$58.6K |
Top Sellers
| 1 | -$795K | |
| 2 | -$252K | |
| 3 | -$162K | |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$118K |
| 5 |
Jane Street
New York
|
-$93.4K |